Results are in general agreement with the hypothesis that 1,25(OH)2D, and probably also FGF-23, plays a pivotal role in the pathogenesis of HF and that mortality remain high in end-stage HF patients, despite LVAD implantation. The gene discussed is FGF23; the disease is hydrops fetalis.